Innate Pharma (IPHA) Shareholder's Equity (2017 - 2025)

Innate Pharma (IPHA) Shareholder's Equity (2017 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - 7.14 Bn
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - 795.79 Mn
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - 595,226.00
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 1.00 Bn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - 14.38 Mn
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 19.36 Bn
9 Abivax 90.15 Bn 90.15 Bn - 502.95 Mn
10 Innate Pharma 194.19 Mn 194.19 Mn - -25.26 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -25.26 Mn
Jun 30, 2025 5.82 Mn
Dec 31, 2024 9.44 Mn
Jun 30, 2024 31.01 Mn
Dec 31, 2023 55.84 Mn
Jun 30, 2023 63.01 Mn
Dec 31, 2022 55.25 Mn
Jun 30, 2022 124.13 Mn
Dec 31, 2021 122.91 Mn
Jun 30, 2021 160.84 Mn
Dec 31, 2020 185.97 Mn
Jun 30, 2020 207.76 Bn
Dec 31, 2019 240.66 Mn
Dec 31, 2018 190.89 Mn
Dec 31, 2017 101.21 Mn